Development and Validation of the Air Quality Awareness Scale (AQAS) for Parents

NCT ID: NCT07283250

Last Updated: 2025-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-11-01

Study Completion Date

2026-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This cross-sectional study aims to assess the level of awareness, knowledge, and preventive behaviors regarding air quality and air pollution among parents of children with physician-diagnosed allergic respiratory diseases (asthma and/or allergic rhinitis). The survey will evaluate parents' understanding of air pollution effects, sources, and protective measures, as well as sociodemographic and clinical correlates influencing awareness.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma (Diagnosis) Air Quality Air Pollution Rhinitis, Allergic Health Knowledge, Attitudes, Practice Health Belief Model Parents

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Parents of Children with Allergic Airway Diseases

This cohort includes parents or primary caregivers of children aged 2-18 years who have been clinically diagnosed with allergic airway diseases (asthma and/or allergic rhinitis) by a pediatric allergy specialist. Participants will complete a structured questionnaire assessing their awareness, knowledge, and preventive behaviors regarding air pollution and air quality.

Air Quality Knowledge Questionnaire

Intervention Type BEHAVIORAL

A structured, self-administered questionnaire on air quality and pollution will be provided to all participants.

The survey consists of a total of 23 main items and an additional demographic information section.

The demographic section collects data on parent's age, gender, education level, occupation, and the child's age, gender, diagnosis (asthma and/or allergic rhinitis), and disease duration.

The main questionnaire includes:

* 5 items assessing knowledge of air pollution and air quality concepts;
* 10 items measuring awareness of air pollution sources, health impacts, and environmental conditions;
* 8 items evaluating attitudes and protective behaviors toward air pollution (e.g., monitoring air quality index, modifying outdoor activities, using indoor air filters).

Responses are based on a Likert-type scale. The tool is designed to quantify parental understanding, awareness, and preventive practices related to air quality in the context of childhood allergic airway diseases.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Air Quality Knowledge Questionnaire

A structured, self-administered questionnaire on air quality and pollution will be provided to all participants.

The survey consists of a total of 23 main items and an additional demographic information section.

The demographic section collects data on parent's age, gender, education level, occupation, and the child's age, gender, diagnosis (asthma and/or allergic rhinitis), and disease duration.

The main questionnaire includes:

* 5 items assessing knowledge of air pollution and air quality concepts;
* 10 items measuring awareness of air pollution sources, health impacts, and environmental conditions;
* 8 items evaluating attitudes and protective behaviors toward air pollution (e.g., monitoring air quality index, modifying outdoor activities, using indoor air filters).

Responses are based on a Likert-type scale. The tool is designed to quantify parental understanding, awareness, and preventive practices related to air quality in the context of childhood allergic airway diseases.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Parent or primary caregiver of a child aged 2-18 years
* Child has a physician-diagnosed asthma and/or allergic rhinitis
* Able to read and understand Turkish
* Provides informed consent

Exclusion Criteria

* Parents of children with other chronic respiratory or systemic diseases
* Parents who are healthcare professionals (to avoid bias)
* Incomplete survey responses
Minimum Eligible Age

20 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hilal Gungor

Medical Doctor, Pediatric Immunology and Allergy

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

Istanbul, Şişli, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-654789651231

Identifier Type: -

Identifier Source: org_study_id